Worldwide Healthcare (WWH) was launched in April 1995. Initially focused on the pharmaceutical industry, it expanded its remit to the entire healthcare sector in 2010. OrbiMed (and its predecessor firm) has been the trust's investment adviser since its IPO with Sven Borho, one of OrbiMed's founders, and Trevor Polischuk taking over as lead managers in 2017 after the departure of Sam Isaly. Up to September 2024, WWH's share price return was 13.6% a year compared to 11.6% for its benchmark and around 9.5% a year for global markets, making WWH one of the top-performing trusts over the last three ...
This is a premium article for our subscribers.
Please log in below to read it, or find out how to join the Money Makers Circle.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.